Reverb Therapeutics
PrivateLast Round
Seed
Feb 19, 2025
Total Funding Raised
$12M
Momentum Score
50 /100
Company Overview
Reverb Therapeutics is a biotechnology company that develops bispecific antibodies designed to redirect the body's own cytokines to treat cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reverb Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Reverb Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 19, 2025 |
Key People
Founding team and executive leadership
Reverb Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InBC Investment Corp. | Seed |
| Finchley Healthcare Ventures | Seed |
| Amplitude Ventures | Seed |
| Myeloma Investment Fund | Seed |
| KdT Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2026
Grew 16% QoQ, from 19 to 22 employees.
Reverb Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Reverb Therapeutics's valuation, stock price, and market status.
